$2.55T
Total marketcap
$170.75B
Total volume
BTC 50.05%     ETH 15.90%
Dominance

Pliant Therapeutics PLRX Stock

14.6 USD {{ price }} -3.884129% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
879.49M USD
LOW - HIGH [24H]
14.56 - 15.49 USD
VOLUME [24H]
281.51K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-2.75 USD

Pliant Therapeutics Price Chart

Pliant Therapeutics PLRX Financial and Trading Overview

Pliant Therapeutics stock price 14.6 USD
Previous Close 24.33 USD
Open 24.2 USD
Bid 0 USD x 1000
Ask 0 USD x 900
Day's Range 23.37 - 24.72 USD
52 Week Range 6.81 - 36.64 USD
Volume 671.93K USD
Avg. Volume 727.37K USD
Market Cap 1.38B USD
Beta (5Y Monthly) 1.403225
PE Ratio (TTM) N/A
EPS (TTM) -2.75 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 46.85 USD

PLRX Valuation Measures

Enterprise Value 877.15M USD
Trailing P/E N/A
Forward P/E -7.002994
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 141.65317
Price/Book (mrq) 2.4551272
Enterprise Value/Revenue 89.798
Enterprise Value/EBITDA -6.298

Trading Information

Pliant Therapeutics Stock Price History

Beta (5Y Monthly) 1.403225
52-Week Change 229.90%
S&P500 52-Week Change 20.43%
52 Week High 36.64 USD
52 Week Low 6.81 USD
50-Day Moving Average 24.28 USD
200-Day Moving Average 24.18 USD

PLRX Share Statistics

Avg. Volume (3 month) 727.37K USD
Avg. Daily Volume (10-Days) 506.89K USD
Shares Outstanding 59.16M
Float 45.16M
Short Ratio 5.63
% Held by Insiders 6.67%
% Held by Institutions 79.01%
Shares Short 5.95M
Short % of Float 10.25%
Short % of Shares Outstanding 10.06%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -1444.34%
Gross Margin 100.00%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -22.18%
Return on Equity (ttm) -36.092%

Income Statement

Revenue (ttm) 9.77M USD
Revenue Per Share (ttm) 0.21 USD
Quarterly Revenue Growth (yoy) 6.60%
Gross Profit (ttm) 9.69M USD
EBITDA -139264000 USD
Net Income Avi to Common (ttm) -132769000 USD
Diluted EPS (ttm) -3.04
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 577.31M USD
Total Cash Per Share (mrq) 9.76 USD
Total Debt (mrq) 15.19M USD
Total Debt/Equity (mrq) 2.7 USD
Current Ratio (mrq) 25.406
Book Value Per Share (mrq) 9.527

Cash Flow Statement

Operating Cash Flow (ttm) -104409000 USD
Levered Free Cash Flow (ttm) -56702248 USD

Profile of Pliant Therapeutics

Country United States
State CA
City South San Francisco
Address 260 Littlefield Avenue
ZIP 94080
Phone 650 481 6770
Website https://pliantrx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 136

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase IIa trials for idiopathic pulmonary fibrosis and primary sclerosing cholangitis. It also develops PLN-1474, a small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Q&A For Pliant Therapeutics Stock

What is a current PLRX stock price?

Pliant Therapeutics PLRX stock price today per share is 14.6 USD.

How to purchase Pliant Therapeutics stock?

You can buy PLRX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Pliant Therapeutics?

The stock symbol or ticker of Pliant Therapeutics is PLRX.

Which industry does the Pliant Therapeutics company belong to?

The Pliant Therapeutics industry is Biotechnology.

How many shares does Pliant Therapeutics have in circulation?

The max supply of Pliant Therapeutics shares is 60.24M.

What is Pliant Therapeutics Price to Earnings Ratio (PE Ratio)?

Pliant Therapeutics PE Ratio is now.

What was Pliant Therapeutics earnings per share over the trailing 12 months (TTM)?

Pliant Therapeutics EPS is -2.75 USD over the trailing 12 months.

Which sector does the Pliant Therapeutics company belong to?

The Pliant Therapeutics sector is Healthcare.

Pliant Therapeutics PLRX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2568.29 USD
+0.16
2566.7 USD 2581.47 USD
NASDAQ Biotechnology NBI 4337.34 USD
-0.65
4335.84 USD 4376.86 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
NASDAQ Global Select Market Com NQGS 7837.41 USD
+0.85
7832.7 USD 7908.95 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD